Federal award
IMPEL PHARMACEUTICALS INC
W81XWH10C0238
ContractSBIR/STTR SR1
Obligated and Ceiling
- Obligated (net)
- $747,974.77
- Ceiling (potential value, not spending)
- $747,974.77
- Current value
- $747,974.77
- Gross positive obligations
- $747,974.77
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- IMPEL PHARMACEUTICALS INC · VGX8L65CX5A3
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- IMPEL PHARMACEUTICALS INC · VGX8L65CX5A3
- Awarding agency
- Department of War · sub-agency 2100 · office W81XWH
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- AN92 · R&D- MEDICAL: OTHER (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Industry (NAICS)
- 541712 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
- PIID
- W81XWH10C0238
- Award type code
- D
- Actions
- 4 · Jul 12, 2010 to Jan 23, 2014
- Why it is listed
- gross positive obligations of $100k or more (contracts); SBIR/STTR award
Action History4
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jan 23, 2014 | FY2014 | P00003 | M | $0.00 | — |
| Aug 3, 2012 | FY2012 | P00002 | M | $222,831.00 | — |
| Nov 18, 2011 | FY2012 | P00001 | C | $455,872.17 | — |
| Jul 12, 2010 | FY2010 | 0 | — | $69,271.60 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.